Gam Holding Ag Horizon Therapeutics Public LTD CO Transaction History

Gam Holding Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	SELL	$98.98 - $115.74 $182,915 - $213,887	-1,848 Reduced 14.32%	11,056 $1.28 Million
Q2 2023 Jul 27, 2023	SELL	$96.34 - $112.38 $414,262 - $483,234	-4,300 Reduced 24.99%	12,904 $1.33 Million
Q1 2023 May 09, 2023	BUY	$107.32 - $113.5 $804,900 - $851,250	7,500 Added 77.29%	17,204 $1.88 Million
Q4 2022 Feb 02, 2023	BUY	$62.39 - $113.8 $605,432 - $1.1 Million	9,704 New	9,704 $1.1 Million
Q4 2019 Feb 06, 2020	SELL	$25.43 - $36.67 $352,002 - $507,586	-13,842 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$23.0 - $27.97 $26,680 - $32,445	-1,160 Reduced 7.73%	13,842 $377,000
Q2 2019 Aug 12, 2019	BUY	$22.81 - $28.48 $342,195 - $427,256	15,002 New	15,002 $361,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.